Biotransformation of a macrolide antibiotic and a related compound was studied using various macrolide-producing microorganisms grown in the presence of cerulenin, an inhibitor of de novo synthesis of the aglycone moiety. Protylonolide (1) was transformed into 5-0-(4'-O-propionylmycarosyl)protylonolide (2) by a leucomycin-producing strain, Streptoverticillium kitasatoensis KA-429. M-4365 G2 (3) was bioconverted into M-4365 G3 (4), 9-dihydro M-4365 G3 (5), 3-O-acetyl M-4365 G3 (6) and 3-O-acetyl-9-dihydro M-4365 G3 (7) by a spiramycinproducing strain, Streptomyces ambofaciens KA-1028. Forosaminylated derivatives of M-4365 G2 were not obtained using this microorganism.
Results and Discussion

Bioconversion of Protylonolide by Sty. kitasatoensis
The compound obtained from protylonolide (1) with a leucomycin-producing strain, Stv. kitasatoensis KA-429, in the presence of cerulenin was determined to be 5-O-(4'-O-propionylmycarosyl)protylonolide (2) on the basis of mass, 1H and 11C NMR spectral data. The 1"C NMR spectrum of 2 indicates the presence of an ester carbonyl at C-1 (i 174.4) and a sugar attached to the oxygen atom at C-5 (d 79. 4) on the lactone ring. The mass fragmentation pattern showed that the sugar at C-5 was 4-O-propionylmycarose.
It is suggested that Stv. kitasatoensis KA-429 cannot attach mycaminose at C-5 nor oxidize the C-20 carbon on protylonolide. In the biosynthesis of its own antibiotic leucomycin, however, the two reactions are carried out on the aglycone moiety, platenolide,7) followed by the attachment of mycarose to mycaminose. Accordingly, strain KA-429 biosynthesized 2 from mycarose and a foreign aglycone, protylonolide, by their direct linkage, a process which is not normally involved in leucomycin biosynthesis.
We reported the isolation of mycarosylprotylonolide8) from a culture of a mutant strain, No. 261, of the tylosin-producing strain, S. fradiae KA-427. This finding and the present results indicate that the substrate specificity of the mycaminose-binding enzyme is high with respect to the aglycone, whereas that of the mycarose-binding enzyme is low in Stv. kitasatoensis and S. fradiae. The propionylation of mycarose in 2 is worth noting, since this strain produces leucomycins Al and A3 as major components, both of which have an isovaleryl group at the C-4" position of mycarose. The corresponding propionyl derivatives are minor components. 
Bioconversion of M-4365 G, by S. ambofaciens
The structures of the bioconvertants of M-4365 G, obtained in the culture of S. ambofaciens in the presence of cerulenin are shown in Fig. 1 . The structures of these bioconvertants were deduced from the mass, UV and 1H NMR spectral data (Table 1) . In the 'H NMR spectrum of 7 ( Fig. 2) , the signal at u 9.74 due to the aldehyde group at C-20 which is observed in the spectrum of 3 was not seen, while a doublet at o 5.16, a singlet at 5 2.11 and a double of doublets at o 4.29 were observed. The signal at o 5.16 was assigned to the methine proton at the 3-position which shifts to a lower magnetic field due to the acetylation of the C-3 hydroxyl group. The signal at 5 4.29 can be assigned to the proton at the C-9 bearing a hydroxyl group. The configuration at C-9 was determined to be R from the J value (J9,10= 9 Hz)9) Moreover, the EI-mass spectrum of 7 showing the molecular ion peak at m/z 611 and the aglycone peak at m/z 437 strongly indicates that the structure of 7 is 3-O-acetyl-9-dihydro M-4365 G3.
The structures of compounds 4, 5 and 6 were determined by comparison of their behavior in 1H NMR spectrometry and mass fragmentation. The structures were confirmed by comparison with corresponding authentic samples, prepared by acetylation and/or reduction of M-4365 G2, using silica gel TLC and mass spectroscopy. This experiment was attempted with the hope to obtain new forosaminylated derivatives of M-4365 G2. However, the desired compounds were not obtained. It is speculated that the forosamine-binding enzyme is highly specific in S. ambofaciens. Compounds 4-7 were found to possess a hydroxyl group at the C-20 position. The results are in agreement with the previous finding10) that tylosin was bioconverted into 9-dihydrotylosin and 9,20-tetrahydrotylosin by S. ambofaciens. Spiramycin was not converted to the alcohol derivative by the spiramycin-producing strain under the same condition. Further, no compound related to the spiramycin family has been reported to possess a hydroxyl group at the C-20 position. It is obvious from the results that S. ambofaciens possesses a macrolide aldehyde-reducing enzyme. The enzyme acted on the aldehyde group of M-4365 G2 and tylosin, but apparently not on that of its own antibiotic spiramycin.
The biosynthetic significance of this enzyme is not known. The difference among macrolides in the susceptibility to the enzyme may be due to the strict substrate specificity of the enzyme, or to the facile permeation of foreign macrolides through the cell membrane of S. ambofaciens as compared with that of spiramycin.
Compounds 6 and 7 have an acetyl group at the C-3 position. This is in agreement with the results of our previous cell-free studies," which indicated that the substrate specificity of the C-3 hydroxyl acylating enzyme is low in S. ambofaciens. producers of the leucomycin group of antibiotics, but not in the producers of the tylosin group of antibiotics. However, such an acylase is produced by various non-macrolide producing microorganisms.12)
The possibility is not ruled out at present that the tylosin-producing microorganism possesses a macrolide 3-hydroxyl acylase, which does not act on its own antibiotic, but does act on foreign macrolide antibiotics, as is the case with the aldehyde-reducing enzyme of S. ambofaciens.
In the experiments described in a previous section, protylonolide was converted to a derivative with a sugar at the C-5 position, but not to a derivative with an acyl group at the C-3 position. The results described above showed that such 3-acylated derivatives were obtained from 5-O-desosaminyl antibiotics.
In view of these findings, it is likely that the acylation of the C-3 hydroxyl group requires the presence of a (amino) sugar moiety at C-5 on the 16-membered lactone ring. cerning not only the structure-activity relationships of the antibiotics but also the properties of the enzymes involved in the biosynthetic reactions. Such information will be useful for manipulating genetic recombination techniques to elaborate new antibiotics in the near future.
Experimental Materials
Protylonolide was obtained by fermentation using a blocked mutant, Streptomyces fradiae KA-427 No. 261, as described in a previous paper.3) Cerulenin was obtained from a fermentation broth of Cephalosporium caerulens KF-140 by a new method (manuscript in preparation).
M-4365 G2 was obtained from Tanabe Seiyaku Co.
Analysis
The microbial transformation was monitored with a Shimadzu CS-920 chromatogram scanner. U V spectra were measured with a Shimadzu UV-210A double-beam spectrophotometer. Mass spectrometric analysis was carried out by means of a JEOL JMS-D 100 spectrometer. 1Hand
13C NMR spectra were recorded with a Varian EM-390 spectrometer and a JEOL PS-100 spectrometer, respectively, with TMS as the internal standard.
Bioconversion of Protylonolide by Stv. kitasatoensis KA-429 A seed culture was prepared by culturing Stv. kitasatoensis KA-429 (66-14-3B) in a seed medium (2.0 % glucose, 0.5 % peptone, 0.5 % meat extract, 0.3 % dried yeast, 0.5 % NaCl, 0.3 % CaCO3, pH 7.0) for 2 days at 27°C. The seed culture (2.0% of inoculum size) was transferred into a 500-m1 Sakaguchi flask containing 100m] of a leucomycin production medium (2.0% glucose, 0.5% peptone, 0.1% meat extract, 0.5 % yeast extract, 0.3 % NaCl, 0.5 % CaCO3, pH 7.0). To the culture medium was added 40 tig/ ml of cerulenin initially and at every 24-hour interval to prevent the de novo synthesis of the lactone moiety. After 8 hours of cultivation, 50 tig/ml of protylonolide was added and the cultivation was continued for a further 64 hours. The cultured broth was centrifuged to remove mycelia and the supernatant was extracted with an equal volume of benzene. The benzene layer was concentrated. Bioconversion of M-4365 G, by S. ambofaciens KA-1028 S. ambofaciens strain KA-1028 (ISP 5053) was cultured in a spiramycin production medium (1% glucose, 1 % dried yeast, 0.1 % NaNO3i 0.5 % NaCl, 1 % CaCO3, pH 7.5) in the presence of cerulenin. After 24 hours, 50 jig/ml of M-4365 G2 was added into the culture and the cultivation was continued for a further 48 hours. The cultured broth was centrifuged to remove mycelia and the bioconvertants in the supernatant fluid were extracted with benzene. The benzene extracts were purified by silica gel column chromatography (CHCl3 -MeOH -conc. NH4OH, 10: 1: 0.05) followed by preparative TLC on silica gel with the same solvent system to afford M-4365 G3 (4), 9-dihydro M-4365 G3 (5), 3-O-acetyl M-4365 G3 (6) and 3-O-acetyl-9-dihydro M-4365 G3 (7) . From 12 liters of the culture to which 600 mg of M-4365 G2 was added, compounds 4 (7.1 mg), 5 (13.5 mg), 6 (6.6 mg) and 7 (13.4 mg) were obtained. Physicochemical properties of these compounds are as follows. M-4365 G3 (4); UV: 2max nm (s) 282. Bioconversion of M-4365 G2 by S. thermotolerans S. thermotolerans strain KA-442 (KCC S-0159) was cultured in a carbomycin production medium
